Skip to main
ALDX
ALDX logo

Aldeyra Therapeutics (ALDX) Market Capitalization Overview

Market Cap: $166.51M as of Jun 13, 2025

$166.51M
Past Month+$37.14M (28.70%)
As of Jun 13, 2025, Aldeyra Therapeutics (ALDX) has a market capitalization of $166.51M. Over the past 30 days, its market cap has decreased by -21.53%, while in the last 12 months, it has decreased by -43.96%.

Market capitalization represents the total value of Aldeyra Therapeutics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Aldeyra Therapeutics (ALDX) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Aldeyra Therapeutics (ALDX) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Aldeyra Therapeutics (ALDX) Market Cap History

DateMarket CapChange
Jun 2, 2025$126.98M-21.53%
May 1, 2025$161.82M-50.50%
Apr 1, 2025$326.91M-9.41%
Mar 3, 2025$360.88M+17.21%
Feb 3, 2025$307.88M-0.96%
Jan 2, 2025$310.85M+8.30%

Aldeyra Therapeutics (ALDX) End of Year Market Cap History

DateMarket CapChange
2025$166.51M-43.96%
2024$297.16M+43.92%
2023$206.47M-49.34%
2022$407.58M+75.40%
2021$232.37M-12.74%
2020$266.31M

FAQs About Aldeyra Therapeutics (ALDX) Market Cap

As of Jun 13, 2025, the market capitalization of Aldeyra Therapeutics (ALDX) is $166.51M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Aldeyra Therapeutics’s market capitalization has increased by 28.70%, changing from $129.38M to $166.51M as of Jun 13, 2025.

In the last 3 months, Aldeyra Therapeutics’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, Aldeyra Therapeutics’s market capitalization increased from $206.47M in January to $297.16M in December, reflecting a 43.92% change.

In the past five years, Aldeyra Therapeutics (ALDX) has had a compound annual growth rate (CAGR) of 2.22% in market capitalization. This means its market cap has grown at an average rate of 2.22% per year.

Aldeyra Therapeutics (ALDX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.